CXCL11 and hepatocellular carcinoma: More importantly, miR-205-5p inhibition in CAFs could significantly attenuate the effects of LINC00152 silencing in CAFs, suggesting that the LINC00152/miR-205-5p axis in CAFs can modulate the expression of CXCL11 and, consequently, affect HCC cell phenotypes.